Plantainoside D
Based on 2 publication(s) in Google Scholar
Plantainoside D, a phenylethanoid glycosides, is a IKK-β inhibitor with diverse biological activities. Plantainoside D shows inhibitory activity of angiotensin-converting enzyme (ACE) with an IC50 of 2.17 mM. Plantainoside D significantly reduces the release of glutamate from nerve terminals in the cerebral cortex of rats by inhibiting the voltage-dependent calcium channel (VDCCs) and protein kinase C (PKC) signaling cascade. Plantainoside D significantly alleviates cell apoptosis by inhibiting the generation of ROS and the activation of NF-κB. Plantainoside D significantly improves acute lung injury (ALI) induced by sepsis by regulating the Sirt3/NLRP3 signaling pathway. Plantainoside D can be used for the study of neuroprotection, antioxidant, anti-inflammation, antihypertension.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.15%
- CAS 番号: 147331-98-4
- 分子式: C29H36O16
- 分子量:640.59
-
保管条件:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
MedChemExpress(MCE)の使用を引用している文献 Plantainoside D
More-
IP
-
In Vivo Efficacy Study
-
Histological Imaging/Staining
-
IF
-
ELISA
Calcium Channel アイソフォーム固有の製品をすべて表示
More
生物活性
|
IKK-β |
Calcium Channel |
NF-κB |
NLRP3 |
ACE 2.17 mM (IC50) |
PKC |
Plantainoside D (0-50 μM, 10 min) significantly inhibits the release of glutamate induced by 4-aminopyridine (4-AP) (HY-B0604) via vesicle exocytosis pathway with an IC50 of 32 μM in rat synaptosome[1].
Plantainoside D (30 μM, 10 min) reduces the Ca2+ influx induced by 4-AP through N-type calcium channels, and does not alter the membrane potential in rat synaptosome[1].
Plantainoside D (30 μM, 20 min) acts through PKC-α/SNAP-25 phosphorylation as its key downstream mechanism in rat synaptosome[1].
Plantainoside D (5 μM, 24 h) significantly improves sepsis induced ALI by regulation of Sirt3/NLRP3 pathway in MLE-12 cells[2].
Plantainoside D (1-20 μg/mL, 1-4 h) significantly reduces the apoptosis induced by Doxorubicin (ADR) (HY-15142A) by inhibiting the generation of ROS and the activation of NF-κB[3].
Plantainoside D exhibits weak inhibitory effects of CYP1A2 (IC50 = 12.83 μM), CYP2D6 (IC50 = 8.39 μM) and CYP3A4 (IC50 = 14.66 μM)[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Rat cerebral cortical synaptosomes
-
Concentration:30 μM
-
Incubation Time:20 min
-
Result:Reduced the phosphorylation of PKC-α (from 239.2% to 54.1%) and SNAP-25 (from 228.9% to 89.7%) induced by 4-AP.
-
Cell Line:MLE-12 cells induced by LPS (HY-D1056)
-
Concentration:5 μM
-
Incubation Time:24 h
-
Result:Increased cell vitality, reduced ROS and MDA.
-
Cell Line:H9c2 cell with ADR
-
Concentration:1, 5, 10, 20 μg/mL
-
Incubation Time:1 h
-
Result:Reduced the cell mortality rate with 20 μg/mL pretreatment.
Reduced apoptotic morphology (nuclear enrichment, fragmentation).
Increased Bcl-2/Bax ratio and inhibited caspase-3.
-
Cell Line:H9c2 cell with ADR
-
Concentration:2 μM
-
Incubation Time:15 min, 30 min, 1h, 2h, 4h
-
Result:Abrogated the activation of NF-κB.
The glycoside reduced the degradation of IkBα in ADR-treated cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:LPS-induced ALI model established in ICR WT male mice (6 weeks, 16-18 g)[2]
-
Dosage:50 mg/kg
-
Administration:Intraperitoneal injection (i.p.), once daily for 7 days
-
Result:Significantly decreased the levels of w/d, ROS and MPO.
Significantly decreased MDA and increased SOD and GSH-px in serum and lung tissues.
Significantly restored oxidative stress and neutrophil infiltration.
Significantly decreased the levels of cytokines TNF-α, IL-1β, IL-6, NLRP3, ASC and caspase-1.
化学情報
-
CAS 番号 147331-98-4
-
性状 Solid
-
分子量 640.59
-
分子式 C29H36O16
-
Color White to light yellow
-
SMILES
O[C@H]([C@H]([C@@H]([C@@H](COC(/C=C/C1=CC=C(O)C(O)=C1)=O)O2)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)[C@@H]2OCCC4=CC=C(O)C(O)=C4
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Redox Biol
Extracellular vesicle-packaged GBP2 from macrophages aggravates sepsis-induced acute lung injury by promoting ferroptosis in pulmonary vascular endothelial cells. [Abstract]2025 May:82:103614. PMID: 40156957
Plantainoside D purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 May:82:103614. [Abstract]
Representative images of immunoblotting of GPX4 protein and its ubiquitination levels in HPMECs co-cultured with SMφ-EVs, with or without Plantainoside D (PD) (10 μM) treatment.
Plantainoside D purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 May:82:103614. [Abstract]
Survival rate of mice treated with or without CLP following administration of AAV-shGbp2 or Plantainoside D PD (30 mg/kg, i.v.) treatment.
Plantainoside D purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 May:82:103614. [Abstract]
Representative images of Evans blue staining and HE staining of mouse lungs treated with Plantainoside D PD (30 mg/kg, i.v.).
Plantainoside D purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 May:82:103614. [Abstract]
Representative images and quantification of Tunel staining of mouse lungs treated with Plantainoside D PD (30 mg/kg, i.v.).
Plantainoside D purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 May:82:103614. [Abstract]
Quantification of IL-6, TNF-α and IL-1β in mouse lungs treated with Plantainoside D PD (30 mg/kg, i.v.).
-
Biochem Pharmacol
KCMF1 regulates HRI ubiquitination to inhibit the integrated stress response in ovarian cancer. [Abstract]2026 Mar:245:117634. PMID: 41391693
溶剤 & 溶解度
DMSO : 250 mg/mL (390.27 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (3.25 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション
-
データシート (283 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Chiu KM, et al. Plantainoside D Reduces Depolarization-Evoked Glutamate Release from Rat Cerebral Cortical Synaptosomes. Molecules. 2023 Jan 30;28(3):1313. [Content Brief]
[2]. Wang J, et al. Sirt3 regulates NLRP3 and participates in the effects of plantainoside D on acute lung injury sepsis. Aging (Albany NY). 2023 Apr 5;15(14):6710-6720. [Content Brief]
[3]. Kim DS, et al. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Life Sci. 2007 Jan 2;80(4):314-23. [Content Brief]
[4]. Zhou J, et al. Human liver microsomes study on the inhibitory effect of plantainoside D on the activity of cytochrome P450 activity. BMC Complement Med Ther. 2022 Jul 23;22(1):197. [Content Brief]
[5]. Geng F, Yang L, Chou G, Wang Z. Bioguided isolation of angiotensin-converting enzyme inhibitors from the seeds of Plantago asiatica L. Phytother Res. 2010;24(7):1088-1094. [Content Brief]
[6]. Zhou P, Hua F, Wang X, Huang JL. Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases. Inflammopharmacology. 2020;28(1):19-37. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.5611 mL | 7.8053 mL | 15.6106 mL | 39.0265 mL |
| 5 mM | 0.3122 mL | 1.5611 mL | 3.1221 mL | 7.8053 mL | |
| 10 mM | 0.1561 mL | 0.7805 mL | 1.5611 mL | 3.9027 mL | |
| 15 mM | 0.1041 mL | 0.5204 mL | 1.0407 mL | 2.6018 mL | |
| 20 mM | 0.0781 mL | 0.3903 mL | 0.7805 mL | 1.9513 mL | |
| 25 mM | 0.0624 mL | 0.3122 mL | 0.6244 mL | 1.5611 mL | |
| 30 mM | 0.0520 mL | 0.2602 mL | 0.5204 mL | 1.3009 mL | |
| 40 mM | 0.0390 mL | 0.1951 mL | 0.3903 mL | 0.9757 mL | |
| 50 mM | 0.0312 mL | 0.1561 mL | 0.3122 mL | 0.7805 mL | |
| 60 mM | 0.0260 mL | 0.1301 mL | 0.2602 mL | 0.6504 mL | |
| 80 mM | 0.0195 mL | 0.0976 mL | 0.1951 mL | 0.4878 mL | |
| 100 mM | 0.0156 mL | 0.0781 mL | 0.1561 mL | 0.3903 mL |